Literature DB >> 12942342

Chronic bronchitis in immunocompromised patients: association with a novel Mycoplasma species.

D Webster1, H Windsor, C Ling, D Windsor, D Pitcher.   

Abstract

Patients with primary antibody deficiency are prone to recurrent bronchitis, often caused by nonencapsulated Haemophilus influenzae and streptococcal infection. Productive cough often persists even after elimination of these organisms with antibiotics. During an investigation into the cause of unexplained chronic bronchitis in these patients, a novel Mycoplasma species (designated A39) was first isolated from the sputum of a man with X-linked agammaglobulinaemia. Screening of sputa from a further 45 patients with primary antibody deficiency showed that 10 were positive for a similar organism using culture and/or a polymerase chain reaction based on sequences within the 16S ribosomal RNA gene. A comparison of the sequence data showed that the organism was distinct from but similar to Mycoplasma pneumoniae and other closely related mycoplasmas found in humans and animals. Electron microscopy showed some unique morphological characteristics. Although respiratory symptoms improved after elimination of A39 from the sputum of the patient with X-linked agammaglobulinaemia, further work is needed to establish the organism as a pathogen.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12942342     DOI: 10.1007/s10096-003-0980-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  19 in total

1.  Primary immunodeficiency diseases: an update.

Authors:  H Chapel; R Geha; F Rosen
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

2.  Characterization of Haemophilus influenzae isolates from the respiratory tract of patients with primary antibody deficiencies: evidence for persistent colonizations.

Authors:  A Samuelson; S Borrelli; R Gustafson; L Hammarström; C I Smith; J Jonasson; A A Lindberg
Journal:  Scand J Infect Dis       Date:  1995

Review 3.  Characterization of mycoplasmas by PCR and sequence analysis with universal 16S rDNA primers.

Authors:  K E Johansson; M U Heldtander; B Pettersson
Journal:  Methods Mol Biol       Date:  1998

Review 4.  Biochemical characteristics in mycoplasma identification.

Authors:  J B Poveda
Journal:  Methods Mol Biol       Date:  1998

5.  The mode of action of pleuromutilin derivatives. Effect on cell-free polypeptide synthesis.

Authors:  L A Hodgin; G Högenauer
Journal:  Eur J Biochem       Date:  1974-09-16

6.  Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications.

Authors:  R A Hermaszewski; A D Webster
Journal:  Q J Med       Date:  1993-01

7.  Inhibitory effect of salivary fluids on PCR: potency and removal.

Authors:  A S Ochert; A W Boulter; W Birnbaum; N W Johnson; C G Teo
Journal:  PCR Methods Appl       Date:  1994-06

8.  Treatment of resistant mycoplasma infection in immunocompromised patients with a new pleuromutilin antibiotic.

Authors:  C Heilmann; L Jensen; J S Jensen; K Lundstrom; D Windsor; H Windsor; D Webster
Journal:  J Infect       Date:  2001-11       Impact factor: 6.072

Review 9.  Mycoplasmas as cofactors in infection due to the human immunodeficiency virus.

Authors:  L Montagnier; A Blanchard
Journal:  Clin Infect Dis       Date:  1993-08       Impact factor: 9.079

10.  Use of a triplex polymerase chain reaction for the detection and differentiation of Mycoplasma pneumoniae and Mycoplasma genitalium in the presence of human DNA.

Authors:  N Cadieux; P Lebel; R Brousseau
Journal:  J Gen Microbiol       Date:  1993-10
View more
  8 in total

Review 1.  Mycoplasmas and ureaplasmas as neonatal pathogens.

Authors:  Ken B Waites; Brenda Katz; Robert L Schelonka
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

Review 2.  Mycoplasma pneumoniae Infections and Primary Immune Deficiencies.

Authors:  Dimitri Poddighe; Erkan Demirkaya; Vitaliy Sazonov; Micol Romano
Journal:  Int J Clin Pract       Date:  2022-07-08       Impact factor: 3.149

3.  Biological enrichment of Mycoplasma agents by cocultivation with permissive cell cultures.

Authors:  Dmitriy V Volokhov; Hyesuk Kong; Joseph George; Christine Anderson; Vladimir E Chizhikov
Journal:  Appl Environ Microbiol       Date:  2008-07-07       Impact factor: 4.792

Review 4.  Clinical immunology review series: An approach to the management of pulmonary disease in primary antibody deficiency.

Authors:  M D Tarzi; S Grigoriadou; S B Carr; L M Kuitert; H J Longhurst
Journal:  Clin Exp Immunol       Date:  2009-02       Impact factor: 4.330

5.  Tools for detection of Mycoplasma amphoriforme: a primary respiratory pathogen?

Authors:  Clare L Ling; Katarina Oravcova; Thomas F Beattie; Dean D Creer; Paul Dilworth; Naomi L Fulton; Alison Hardie; Michelle Munro; Marcus Pond; Kate Templeton; David Webster; Sarita Workman; Timothy D McHugh; Stephen H Gillespie
Journal:  J Clin Microbiol       Date:  2014-01-29       Impact factor: 5.948

6.  Novel hemotropic mycoplasmas are widespread and genetically diverse in vampire bats.

Authors:  D V Volokhov; D J Becker; L M Bergner; M S Camus; R J Orton; V E Chizhikov; S M Altizer; D G Streicker
Journal:  Epidemiol Infect       Date:  2017-10-24       Impact factor: 2.451

Review 7.  [Clinical implications of the genus Mycoplasma].

Authors:  D Gómez Rufo; E García Sánchez; J E García Sánchez; M García Moro
Journal:  Rev Esp Quimioter       Date:  2021-03-18       Impact factor: 1.553

8.  Genomic Investigations unmask Mycoplasma amphoriforme, a new respiratory pathogen.

Authors:  Stephen H Gillespie; Clare L Ling; Katarina Oravcova; Miguel Pinheiro; Louise Wells; Josephine M Bryant; Timothy D McHugh; Cecile Bébéar; David Webster; Simon R Harris; Helena M B Seth-Smith; Nicholas R Thomson
Journal:  Clin Infect Dis       Date:  2014-10-23       Impact factor: 9.079

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.